PCRX vs PAHC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 21, 2026
PCRX
PAHC
Investment Advisor Scores
PAHC
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PCRX | PAHC | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.25 | 13.8313 | PCRX |
| PEG Ratio | 11.2121 | 1.6791 | PAHC |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 6.2% | 4.8% | PCRX |
| Earnings Growth | -30.0% | 24.6% | PAHC |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 29.9/100 | 47.3/100 | PAHC |
| Profit Margin | 2.0% | 6.6% | PAHC |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PCRX
MarkupPrice above SMA50, rising 50-day trend (8.8% over 20 days), RSI 84
PAHC
MarkupPrice above SMA50, rising 50-day trend (2.7% over 20 days), RSI 66
Fundamentals Snapshot
| Metric | PCRX | PAHC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.5 | 11.9 |
| Trailing P/E | 103.8 | 16.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.8% | 0.3% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 0.35 | 2.46 |
| Dividend Yield | — | 0.01% |